As we wait for the EMA’s decision, a top Norwegian health official tasked with investigating a series of three high-profile cases of health-care workers under the age of 50 being hospitalized for similar cases of rare blood clots after receiving the AstraZeneca vaccine have proposed a theory that’s bound to infuriate AstraZeneca, along with the EMA…
Day: April 9, 2021
Hooman Noorchashm reports “A Letter To Robert F. Kennedy Jr. And Friends: On COVID-19 Vaccine Efficacy, Safety, and the Potential Danger Of Indiscriminate Vaccination In The Already Infected”
The COVID-19 vaccine was tested too rapidly and the clinical trials, which demonstrated its extreme efficacy in creating immunity, did not have sufficient granularity to assess its safety in certain subsets of the population. Again, as a cellular immunologist, my thinking about the safety of this vaccine does not operate in generalities. Rather, I ask: what…
Frontiers in Immunology reports “Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases”
We sought to determine whether immune reactivity occurs between anti-SARS-CoV-2 protein antibodies and human tissue antigens, and whether molecular mimicry between COVID-19 viral proteins and human tissues could be the cause. We applied both human monoclonal anti-SARS-Cov-2 antibodies (spike protein, nucleoprotein) and rabbit polyclonal anti-SARS-Cov-2 antibodies (envelope protein, membrane protein) to 55 different tissue antigens….